TrialThe British journal of dermatology2021

Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.

J I Silverberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.